Xie Y, Xiao H, Zheng D, Mahai G, Li Y, Xia W
Nat Commun. 2025; 16(1):2089.
PMID: 40025012
PMC: 11873229.
DOI: 10.1038/s41467-025-57253-3.
Ying J, Zhang M, Wei K, Wong S, Subramaniam M
Front Microbiol. 2025; 15():1401597.
PMID: 39850141
PMC: 11755156.
DOI: 10.3389/fmicb.2024.1401597.
Song Y, Xia S, Sun Z, Chen Y, Jiao L, Wan W
World J Psychiatry. 2025; 15(1):101186.
PMID: 39831024
PMC: 11684224.
DOI: 10.5498/wjp.v15.i1.101186.
Prince N, Peralta Marzal L, Roussin L, Monnoye M, Philippe C, Maximin E
Gut Microbes. 2025; 17(1):2447822.
PMID: 39773319
PMC: 11730631.
DOI: 10.1080/19490976.2024.2447822.
Kang N, Sargsyan S, Chough I, Petrick L, Liao J, Chen W
Environ Pollut. 2024; 361:124729.
PMID: 39147228
PMC: 11902886.
DOI: 10.1016/j.envpol.2024.124729.
Metabolomic changes in children with autism.
Al-Beltagi M, Saeed N, Bediwy A, Elbeltagi R
World J Clin Pediatr. 2024; 13(2):92737.
PMID: 38947988
PMC: 11212761.
DOI: 10.5409/wjcp.v13.i2.92737.
Identification of brain-enriched proteins in CSF as biomarkers of relapsing remitting multiple sclerosis.
Wurtz L, Knyazhanskaya E, Sohaei D, Prassas I, Pittock S, Willrich M
Clin Proteomics. 2024; 21(1):42.
PMID: 38880880
PMC: 11181608.
DOI: 10.1186/s12014-024-09494-5.
Untargeted urine metabolomics and machine learning provide potential metabolic signatures in children with autism spectrum disorder.
Liu X, Sun X, Guo C, Huang Z, Chen Y, Feng F
Front Psychiatry. 2024; 15:1261617.
PMID: 38445087
PMC: 10912307.
DOI: 10.3389/fpsyt.2024.1261617.
Host-microbiome orchestration of the sulfated metabolome.
DAgostino G, Chaudhari S, Devlin A
Nat Chem Biol. 2024; 20(4):410-421.
PMID: 38347214
PMC: 11095384.
DOI: 10.1038/s41589-023-01526-9.
Neuronal knockdown of Cullin3 as a Drosophila model of autism spectrum disorder.
Tener S, Lin Z, Park S, Oraedu K, Ulgherait M, Van Beek E
Sci Rep. 2024; 14(1):1541.
PMID: 38233464
PMC: 10794434.
DOI: 10.1038/s41598-024-51657-9.
Using urine FTIR spectra to screen autism spectrum disorder.
Sarigul N, Bozatli L, Kurultak I, Korkmaz F
Sci Rep. 2023; 13(1):19466.
PMID: 37945643
PMC: 10636094.
DOI: 10.1038/s41598-023-46507-z.
Bisphenol-A and phthalate metabolism in children with neurodevelopmental disorders.
Stein T, Schluter M, Steer R, Ming X
PLoS One. 2023; 18(9):e0289841.
PMID: 37703261
PMC: 10499243.
DOI: 10.1371/journal.pone.0289841.
Metabolomics: Perspectives on Clinical Employment in Autism Spectrum Disorder.
Siracusano M, Arturi L, Riccioni A, Noto A, Mussap M, Mazzone L
Int J Mol Sci. 2023; 24(17).
PMID: 37686207
PMC: 10487559.
DOI: 10.3390/ijms241713404.
Liposomal Epigallocatechin-3-Gallate for the Treatment of Intestinal Dysbiosis in Children with Autism Spectrum Disorder: A Comprehensive Review.
de la Rubia Orti J, Moneti C, Serrano-Ballesteros P, Castellano G, Bayona-Babiloni R, Carriqui-Suarez A
Nutrients. 2023; 15(14).
PMID: 37513683
PMC: 10383799.
DOI: 10.3390/nu15143265.
Investigating the Urinary Metabolome in the First Year of Life and Its Association with Later Diagnosis of Autism Spectrum Disorder or Non-Typical Neurodevelopment in the MARBLES Study.
Sotelo-Orozco J, Schmidt R, Slupsky C, Hertz-Picciotto I
Int J Mol Sci. 2023; 24(11).
PMID: 37298406
PMC: 10254021.
DOI: 10.3390/ijms24119454.
Obese-associated gut microbes and derived phenolic metabolite as mediators of excessive motivation for food reward.
de Wouters dOplinter A, Verce M, Huwart S, Lessard-Lord J, Depommier C, Van Hul M
Microbiome. 2023; 11(1):94.
PMID: 37106463
PMC: 10142783.
DOI: 10.1186/s40168-023-01526-w.
Carnosine and Beta-Alanine Supplementation in Human Medicine: Narrative Review and Critical Assessment.
Cesak O, Vostalova J, Vidlar A, Bastlova P, Student Jr V
Nutrients. 2023; 15(7).
PMID: 37049610
PMC: 10096773.
DOI: 10.3390/nu15071770.
Intestinal Barrier Dysfunction and Microbiota-Gut-Brain Axis: Possible Implications in the Pathogenesis and Treatment of Autism Spectrum Disorder.
Dargenio V, Dargenio C, Castellaneta S, De Giacomo A, Laguardia M, Schettini F
Nutrients. 2023; 15(7).
PMID: 37049461
PMC: 10096948.
DOI: 10.3390/nu15071620.
Folate-Methionine Cycle Disruptions in ASD Patients and Possible Interventions: A Systematic Review.
Roufael M, Bitar T, Sacre Y, Andres C, Hleihel W
Genes (Basel). 2023; 14(3).
PMID: 36980981
PMC: 10048251.
DOI: 10.3390/genes14030709.
Metabolomic Signatures of Autism Spectrum Disorder.
Brister D, Rose S, Delhey L, Tippett M, Jin Y, Gu H
J Pers Med. 2022; 12(10).
PMID: 36294866
PMC: 9604590.
DOI: 10.3390/jpm12101727.